Biotech Stocks Face Volatility Amid Increased Speculation on Clinical TrialsBiotech buzz: AI promises breakthroughs, but biological limits and market volatility keep retail investors cautious—discover the real risks and rewards. ai-finance ai-bio ai-science Jonathan Reeve 30/10/2026, 13:01 2 minutes to read
